<VariationArchive VariationID="39752" VariationName="NM_145239.3(PRRT2):c.649del (p.Arg217fs)" VariationType="Deletion" Accession="VCV000039752" Version="55" RecordType="classified" NumberOfSubmissions="20" NumberOfSubmitters="19" DateLastUpdated="2024-07-29" DateCreated="2015-02-24" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="48351" VariationID="39752">
      <GeneList>
        <Gene Symbol="MVP-DT" FullName="MVP divergent transcript" GeneID="112268170" HGNC_ID="HGNC:56029" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29808644" stop="29820367" display_start="29808644" display_stop="29820367" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="PRRT2" FullName="proline rich transmembrane protein 2" GeneID="112476" HGNC_ID="HGNC:30500" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29812193" stop="29815881" display_start="29812193" display_stop="29815881" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="29823408" stop="29827201" display_start="29823408" display_stop="29827201" Strand="+" />
          </Location>
          <OMIM>614386</OMIM>
          <Haploinsufficiency last_evaluated="2021-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PRRT2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PRRT2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_145239.3(PRRT2):c.649del (p.Arg217fs)</Name>
      <CanonicalSPDI>NC_000016.10:29813694:CCCCCCCCC:CCCCCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29813695" stop="29813695" display_start="29813695" display_stop="29813695" variantLength="1" positionVCF="29813694" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="29825016" stop="29825016" display_start="29825016" display_stop="29825016" variantLength="1" positionVCF="29825015" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>R217fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.29813703del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.29813703del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.29825024del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.29825024del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032039.1" sequenceAccession="NG_032039" sequenceVersion="1" change="g.6616del">
            <Expression>NG_032039.1:g.6616del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256442.2" sequenceAccession="NM_001256442" sequenceVersion="2" change="c.649del">
            <Expression>NM_001256442.2:c.649del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243371.1" sequenceAccession="NP_001243371" sequenceVersion="1" change="p.Arg217fs">
            <Expression>NP_001243371.1:p.Arg217fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256443.2" sequenceAccession="NM_001256443" sequenceVersion="2" change="c.649del">
            <Expression>NM_001256443.2:c.649del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243372.1" sequenceAccession="NP_001243372" sequenceVersion="1" change="p.Arg217fs">
            <Expression>NP_001243372.1:p.Arg217fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145239.3" sequenceAccession="NM_145239" sequenceVersion="3" change="c.649del" MANESelect="true">
            <Expression>NM_145239.3:c.649del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_660282.2" sequenceAccession="NP_660282" sequenceVersion="2" change="p.Arg217fs">
            <Expression>NP_660282.2:p.Arg217fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145239.2" sequenceAccession="NM_145239" sequenceVersion="2" change="c.641delC">
            <Expression>NM_145239.2:c.641delC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145239.3" sequenceAccession="NM_145239" sequenceVersion="3" change="c.649delC" MANESelect="true">
            <Expression>NM_145239.3:c.649delC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256442.1" sequenceAccession="NM_001256442" sequenceVersion="1" change="c.649delC">
            <Expression>NM_001256442.1:c.649delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="614386.0011" DB="OMIM" />
        <XRef Type="rs" ID="587778771" DB="dbSNP" />
        <XRef ID="CA261215" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649del (p.Arg217fs) AND Episodic kinesigenic dyskinesia 1" Accession="RCV000032970" Version="17">
        <ClassifiedConditionList TraitSetID="6917">
          <ClassifiedCondition DB="MedGen" ID="C4552000">Episodic kinesigenic dyskinesia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-29" SubmissionCount="4">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649del (p.Arg217fs) AND not provided" Accession="RCV000188778" Version="34">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-08-15" SubmissionCount="8">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649del (p.Arg217fs) AND Episodic kinesigenic dyskinesia" Accession="RCV000820557" Version="9">
        <ClassifiedConditionList TraitSetID="44946">
          <ClassifiedCondition DB="MedGen" ID="C1868682">Episodic kinesigenic dyskinesia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649del (p.Arg217fs) AND Seizures, benign familial infantile, 2" Accession="RCV001253175" Version="9">
        <ClassifiedConditionList TraitSetID="8089">
          <ClassifiedCondition DB="MedGen" ID="C1853995">Seizures, benign familial infantile, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649del (p.Arg217fs) AND multiple conditions" Accession="RCV002496495" Version="4">
        <ClassifiedConditionList TraitSetID="10132">
          <ClassifiedCondition DB="MedGen" ID="C4552000">Episodic kinesigenic dyskinesia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865926">Infantile convulsions and choreoathetosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1853995">Seizures, benign familial infantile, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649del (p.Arg217fs) AND Infantile convulsions and choreoathetosis" Accession="RCV003389315" Version="2">
        <ClassifiedConditionList TraitSetID="8088">
          <ClassifiedCondition DB="MedGen" ID="C1865926">Infantile convulsions and choreoathetosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649del (p.Arg217fs) AND PRRT2-related disorder" Accession="RCV004532478" Version="2">
        <ClassifiedConditionList TraitSetID="79405">
          <ClassifiedCondition>PRRT2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.649del (p.Arg217fs) AND Inborn genetic diseases" Accession="RCV003242966" Version="5">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-29" NumberOfSubmissions="20" NumberOfSubmitters="19" DateCreated="2015-02-24" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22623405</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22744660</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23077016</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24370076</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24755245</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25449067</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25522171</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26598493</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27172900</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28906077</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29215089</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31722684</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PRRT2</URL>
        </Citation>
        <DescriptionHistory Dated="2020-01-08">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="79405" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PRRT2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="44946" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36813" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Episodic kinesigenic dyskinesia</ElementValue>
                <XRef ID="MONDO:0044202" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS128200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal kinesigenic dyskinesia</ElementValue>
                <XRef ID="98809" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial paroxysmal dystonia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EKD</ElementValue>
                <XRef ID="MONDO:0044202" DB="MONDO" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8721" />
                <XRef ID="8721" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98809" DB="Orphanet" />
              <XRef ID="C1868682" DB="MedGen" />
              <XRef ID="MONDO:0044202" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS128200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8088" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Infantile convulsions and choreoathetosis</ElementValue>
                <XRef ID="MONDO:0011178" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile convulsions and paroxysmal choreoathetosis, familial</ElementValue>
                <XRef ID="Infantile+convulsions+and+paroxysmal+choreoathetosis%2C+familial/3804" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Convulsions, infantile, with paroxysmal choreoathetosis, familial</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ICCA</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD/IC</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8553" />
                <XRef ID="8553" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="31709" DB="Orphanet" />
              <XRef ID="C1865926" DB="MedGen" />
              <XRef ID="MONDO:0011178" DB="MONDO" />
              <XRef Type="MIM" ID="602066" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8089" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1006" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Seizures, benign familial infantile, 2</ElementValue>
                <XRef ID="MONDO:0011593" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BFIC2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BFIS2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16504" />
                <XRef ID="16504" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="306" DB="Orphanet" />
              <XRef ID="C1853995" DB="MedGen" />
              <XRef ID="MONDO:0011593" DB="MONDO" />
              <XRef Type="MIM" ID="605751" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10132" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Infantile convulsions and choreoathetosis</ElementValue>
                <XRef ID="MONDO:0011178" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile convulsions and paroxysmal choreoathetosis, familial</ElementValue>
                <XRef ID="Infantile+convulsions+and+paroxysmal+choreoathetosis%2C+familial/3804" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Convulsions, infantile, with paroxysmal choreoathetosis, familial</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ICCA</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD/IC</ElementValue>
                <XRef Type="MIM" ID="602066" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8553" />
                <XRef ID="8553" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="31709" DB="Orphanet" />
              <XRef ID="C1865926" DB="MedGen" />
              <XRef ID="MONDO:0011178" DB="MONDO" />
              <XRef Type="MIM" ID="602066" DB="OMIM" />
            </Trait>
            <Trait ID="1006" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Seizures, benign familial infantile, 2</ElementValue>
                <XRef ID="MONDO:0011593" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BFIC2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BFIS2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16504" />
                <XRef ID="16504" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="306" DB="Orphanet" />
              <XRef ID="C1853995" DB="MedGen" />
              <XRef ID="MONDO:0011593" DB="MONDO" />
              <XRef Type="MIM" ID="605751" DB="OMIM" />
            </Trait>
            <Trait ID="1187" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial Paroxysmal Kinesigenic Dyskinesia</ElementValue>
                <XRef ID="NBK1460" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic kinesigenic dyskinesia 1</ElementValue>
                <XRef ID="MONDO:0007494" DB="MONDO" />
                <XRef ID="MONDO:0100352" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PxMD-PRRT2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 10</ElementValue>
                <XRef ID="Dystonia+10/2407" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal kinesigenic choreoathetosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT10</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKC</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EKD1</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8721" />
                <XRef ID="8721" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="98809" DB="Orphanet" />
              <XRef ID="C4552000" DB="MedGen" />
              <XRef ID="MONDO:0100352" DB="MONDO" />
              <XRef Type="MIM" ID="128200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6917" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1187" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial Paroxysmal Kinesigenic Dyskinesia</ElementValue>
                <XRef ID="NBK1460" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic kinesigenic dyskinesia 1</ElementValue>
                <XRef ID="MONDO:0007494" DB="MONDO" />
                <XRef ID="MONDO:0100352" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PxMD-PRRT2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 10</ElementValue>
                <XRef ID="Dystonia+10/2407" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal kinesigenic choreoathetosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT10</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKC</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EKD1</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8721" />
                <XRef ID="8721" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="98809" DB="Orphanet" />
              <XRef ID="C4552000" DB="MedGen" />
              <XRef ID="MONDO:0100352" DB="MONDO" />
              <XRef Type="MIM" ID="128200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="447147" SubmissionDate="2022-05-16" DateLastUpdated="2023-03-04" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="GDXSV:227484" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000242402" DateUpdated="2023-03-04" DateCreated="2015-08-07" Type="SCV" Version="12" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Common pathogenic variant that accounts for approximately 4% of all pathogenic variants in the PRRT2 gene (Ebrahimi-Fakhari et al., 2015); Reported previously in unrelated individuals with PRRT2-related disorders (Meneret et al., 2012; Yang et al., 2013; Ebrahimi-Fakhari et al., 2015); Published functional studies in transfected HEK cells demonstrate a damaging effect as this variant results in a protein that fails to target to the cell membrane (Liu et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25522171, 22870186, 23077016, 26446061, 24755245, 23551744, 25060993, 24609974, 24101679, 22752065, 23165339, 24465263, 25502464, 23363396, 24370076, 25449067, 28906077, 26598493, 29655203, 31487502, 31901402, 31902651, 32369273, 27172900, 34012299, 32651081, 22744660)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:50518</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_104_20220504054205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_106_20220511054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7694694" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="600826|PRRT2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004118515" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The PRRT2 c.649delC variant is predicted to result in a frameshift and premature protein termination (p.Arg217Glufs*12). This variant is among the most frequently reported causes of PRRT2-related epilepsy, accounting for approximately 4% of affected individuals (Ebrahimi-Fakhari et al. 2015. PubMed ID: 26598493). This variant has been reported in patients with paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), and infantile convulsions with paroxysmal choreoathetosis and febrile seizures (MÃ©neret et al. 2012. PubMed ID: 22744660; Brueckner et al. 2014. PubMed ID: 24755245; He et al. 2014. PubMed ID: 25522171; Yang et al. 2013. PubMed ID: 24370076). This variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PRRT2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1855595" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="113497|MedGen:C1868682" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000961274" DateUpdated="2024-02-28" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22623405</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22744660</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22744660</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23077016</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24370076</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24755245</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25522171</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg217Glufs*12) in the PRRT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRRT2 are known to be pathogenic (PMID: 22623405, 22744660). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with clinical features of PRRT2-related conditions (PMID: 22744660, 23077016, 24370076, 24755245, 25522171). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 39752). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.29825016del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1868682" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1380968" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="62116_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000708571" DateUpdated="2018-12-15" DateCreated="2015-10-11" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000708573" DateChanged="2019-08-06" Version="1">
            <Comment Type="MergeComment">SCV000708573 was merged into SCV000708571 to remove duplication.</Comment>
          </Replaced>
          <Replaced Accession="SCV000708572" DateChanged="2019-08-06" Version="1">
            <Comment Type="MergeComment">SCV000708572 was merged into SCV000708571 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2017-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22744660</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24370076</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24755245</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="-" referenceAllele="C" start="29825024" stop="29825024" variantLength="1" />
            <GeneLocation>NM_145239.2:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD126062" />
            <XRef DB="dbSNP" ID="730882071" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PRRT2</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3001394" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_145239.2:c.649delC|OMIM:128200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001526179" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22744660</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24755245</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25522171</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28906077</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27172900</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24370076</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25449067</ID>
          </Citation>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease-causing in multiple individuals [PMID 22744660, 24755245, 25522171, 28906077, 27172900, 24370076, 25449067]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5456314" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_145239.3:c.649del|OMIM:128200;602066;605751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002810909" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3963170" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="7a5add094d25edb0e7e7a3eb758bb5194c0cb1a3fb9ec46aed1cd4d59c9e9a40|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002019532" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="93948" SubmissionDate="2015-02-19" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="614386.0011_EPISODIC KINESIGENIC DYSKINESIA 1" title="PRRT2, 1-BP DEL, 649C_EPISODIC KINESIGENIC DYSKINESIA 1" />
        <ClinVarAccession Accession="SCV000056745" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-07-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 unrelated children of European descent with episodic kinesigenic dyskinesia-1 (EKD1; 128200), Meneret et al. (2012) identified a heterozygous 1-bp deletion (649delC) in the PRRT2 gene, resulting in a frameshift and premature termination (Arg217GlufsTer12). This deletion occurred at the same nucleotide of a common duplication mutation (649dupC; 614386.0001), suggesting a mutation hotspot. One patient had a family history of the disorder. The other patient was thought to have sporadic disease, but the mutation was found in a parent, indicating incomplete penetrance.</Attribute>
              <Citation>
                <ID Source="PubMed">22744660</ID>
              </Citation>
              <XRef DB="OMIM" ID="128200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <Name>PRRT2, 1-BP DEL, 649C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 649C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614386.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPISODIC KINESIGENIC DYSKINESIA 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5003526" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_145239_2_PRRT2_c_649delC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002557720" DateUpdated="2024-07-23" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22744660</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31722684</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with PRRT2-related disorder. (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance (PMID:22744660). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) &lt;0.001 for a dominant condition (2 heterozygotes, 0 homozygotes). (SP) 0701 - Other NMD variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar, DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals with PRRT2-related disorders (ClinVar), and has been found in 20 to 45% of the patients with paroxysmal kinesigenic dyskinesia (PMID: 31722684). (SP) 1205 - This variant has been shown to be maternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_3323</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0011593" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2245886" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000016.9:g.29825016delC|OMIM:128200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001140083" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.29825016delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2819924" SubmissionDate="2020-04-20" DateLastUpdated="2020-08-16" DateCreated="2020-08-16">
        <ClinVarSubmissionID localKey="CV_152|OMIM:605751" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001428758" DateUpdated="2020-08-16" DateCreated="2020-08-16" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.649del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7303396</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3430018" SubmissionDate="2021-09-02" DateLastUpdated="2021-09-08" DateCreated="2021-07-07">
        <ClinVarSubmissionID localKey=":Chr.16_29825015_29825016_GC_G|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001742025" DateUpdated="2021-09-08" DateCreated="2021-07-07" Type="SCV" Version="3" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" OrgID="506382" OrganizationCategory="laboratory" OrgAbbreviation="DL-UMCG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="G" referenceAllele="GC" start="29825015" stop="29825016" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <StudyDescription>VKGL Data-share Consensus</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB10172767</SubmissionName>
          <SubmissionName>SUB10306554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3786372" SubmissionDate="2021-09-23" DateLastUpdated="2021-09-24" DateCreated="2021-09-24">
        <ClinVarSubmissionID localKey=":Chr.16_29825015_29825016_GC_G|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001927007" DateUpdated="2021-09-24" DateCreated="2021-09-24" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, University Medical Center Utrecht" OrgID="274978" OrganizationCategory="laboratory" OrgAbbreviation="GDL-UMCU" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="G" referenceAllele="GC" start="29825015" stop="29825016" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10419633</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3858223" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-07" DateCreated="2021-10-07">
        <ClinVarSubmissionID localKey=":Chr.16_29825015_29825016_GC_G|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001969286" DateUpdated="2021-10-07" DateCreated="2021-10-07" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="G" referenceAllele="GC" start="29825015" stop="29825016" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7534086" SubmissionDate="2023-08-16" DateLastUpdated="2023-08-19" DateCreated="2023-08-19">
        <ClinVarSubmissionID localKey="NM_145239.3:c.649delC|not provided" />
        <ClinVarAccession Accession="SCV004027098" DateUpdated="2023-08-19" DateCreated="2023-08-19" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital" OrgID="505691" OrganizationCategory="laboratory" OrgAbbreviation="GM4113, RH" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13765296</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7575685" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="20300106516" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004047266" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frame shift c.649del (p.Arg217GlufsTer12) variant in the PRRT2 gene has been reported previously in multiple individuals with PRRT2-related disorders (Meneret et al., 2012). This variant has been reported to segregate with PRRT2-related conditions in families (Brueckner F et al., 2014). The p.Arg217GlufsTer12 variant is reported with the allele frequency (0.4%) in the gnomAD and novel in 1000 genome database. This variant has been reported to the ClinVar database as Pathogenic. This variant causes a frameshift starting with codon Arginine 217, changes this amino acid to Glutamic Acid residue, and creates a premature Stop codon at position 12 of the new reading frame, denoted p.Arg217GlufsTer12. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002354" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000750" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001270" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000708" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002372" />
              </Trait>
              <Comment>Clinical details: - Poor memory and subnormal intelligence - Speech delay and motor delay - Behavioral problems (occasional sudden loss of temper) Developmental milestones: Appropriate up to 7 years Age of onset: 7 years Consanguinity: Absent Investigation: - EEG: Norma</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13901154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7681246" SubmissionDate="2023-11-03" DateLastUpdated="2023-11-11" DateCreated="2023-11-11">
        <ClinVarSubmissionID localKey="20300121376" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004101538" DateUpdated="2023-11-11" DateCreated="2023-11-11" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.649delC pathogenic variant in the PRRT2 gene has been reported previously in multiple unrelated individuals affected with Convulsions, familial infantile, with paroxysmal choreoathetosis (Meneret et al., 2012). This variant has been reported to segregate with PRRT2-related conditions in families (Brueckner et. al., 2014) and has been reported in individuals affected with paroxysmal kinesigenic dyskinesia, benign familial infantile epilepsy, hemiplegic migraine, (Meneret et al., 2012; Yang X et. al., 2013). The p.Arg217GlufsTer12 variant is novel (not in any individuals) in 1000 Genomes and has allele frequency of 0.4% in gnomAD database. This variant has been reported to the ClinVar database as Pathogenic/Likely Pathogenic. This variant causes a frameshift starting with codon Arginine 217, changes this amino acid to Glutamic Acid residue, and creates a premature Stop codon at position 12 of the new reading frame, denoted p.Arg217GlufsTer12. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002133" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002160" />
              </Trait>
              <Comment>Age of onset: 4.5 months of age Clinical symptoms: Seizures from 4.5 months of age. status epilepticus and currently on 3 AED. Investigations done: Homocysteine 21.9 (elevated). Clinical suspicion: Meningitis/Pyridoxine Dependent Seizure.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.3:c.649del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602066" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13951554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8988608" SubmissionDate="2024-03-29" DateLastUpdated="2024-04-06" DateCreated="2024-04-06">
        <ClinVarSubmissionID localKey="NM_001256442.2:c.649del|OMIM:128200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004808258" DateUpdated="2024-04-06" DateCreated="2024-04-06" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.2:c.649del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14345716</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7368802" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2023-07-08">
        <ClinVarSubmissionID localKey="a8865951|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003940948" DateUpdated="2024-05-01" DateCreated="2023-07-08" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22744660</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23077016</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24370076</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24755245</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25522171</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26598493</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27172900</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29215089</ID>
          </Citation>
          <Comment>The c.649delC (p.R217Efs*12) alteration, located in exon 2 (coding exon 1) of the PRRT2 gene, consists of a deletion of one nucleotide at position 649, causing a translational frameshift with a predicted alternate stop codon after 12 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, this allele has an overall frequency of 0.001% (2/149480) total alleles studied. The highest observed frequency was 0.007% (1/15022) of Latino/Admixed American alleles. This alteration was reported in several individuals and families with variable phenotypes within the spectrum of PRRT2-related paroxysmal movement disorders (Riant, 2012; M&amp;eacute;neret, 2012; Yang, 2013; He, 2014; Brueckner, 2014; Zeng, 2018). This alteration is found in about 4% of PRRT2-related benign familial infantile epilepsy cases (Ebrahimi-Fakhari, 2015). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.649delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough061523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2470047" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="100460|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001248448" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="21" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="12" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="G" referenceAllele="GC" start="29825015" stop="29825016" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7534086" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7681246" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575685" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002372" MappingRef="HP">
        <MedGen CUI="C1843146" Name="Normal interictal EEG" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575685" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2470047" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5456314" TraitType="Disease" MappingType="XRef" MappingValue="602066" MappingRef="OMIM">
        <MedGen CUI="C1865926" Name="Infantile convulsions and choreoathetosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575685" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002354" MappingRef="HP">
        <MedGen CUI="C0233794" Name="Memory impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8988608" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7681246" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3430018" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2245886" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="447147" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5456314" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="93948" TraitType="Disease" MappingType="Name" MappingValue="EPISODIC KINESIGENIC DYSKINESIA 1" MappingRef="Preferred">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3001394" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7681246" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002133" MappingRef="HP">
        <MedGen CUI="C0038220" Name="Status epilepticus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7694694" TraitType="Disease" MappingType="Name" MappingValue="PRRT2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="PRRT2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2819924" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575685" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000708" MappingRef="HP">
        <MedGen CUI="C0233514" Name="Atypical behavior" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3786372" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3963170" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575685" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000750" MappingRef="HP">
        <MedGen CUI="C0454644" Name="Delayed speech and language development" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1380968" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5003526" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0011593" MappingRef="MONDO">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1855595" TraitType="Disease" MappingType="XRef" MappingValue="C1868682" MappingRef="MedGen">
        <MedGen CUI="C1868682" Name="Episodic kinesigenic dyskinesia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5456314" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575685" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3858223" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575685" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001270" MappingRef="HP">
        <MedGen CUI="C1854301" Name="Motor delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7368802" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7681246" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002160" MappingRef="HP">
        <MedGen CUI="C3806347" Name="Hyperhomocystinemia" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-09">SCV001482969</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

